Clinical response of levofloxacin 500 mg qd to respiratory tract infection

Japanese Journal of Chemotherapy

Volumn 57, Issue SUPPL. 2, 2009, Pages 20-33

  Kohno, Shigeru ^a   Watanabe, Akira ^b   Aoki, Nobuki ^c   Niki, Yoshihito ^d   Kadota, Junichi ^e   Fujita, Jiro ^f   Yanagihara, Katsunori ^a   Kaku, Mitsuo ^g   Hori, Seiji ^h  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c Shinrakuen Hospital   (Japan)

^d SHOWA UNIVERSITY   (Japan)

^e OITA UNIVERSITY   (Japan)

^f UNIVERSITY OF THE RYUKYUS   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Clinical study; Levofloxacin; Once a day; PK PD; Respiratory tract infection

Indexed keywords

LEVOFLOXACIN;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ABNORMAL SENSATION; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANOREXIA; ANTIMICROBIAL THERAPY; ARTICLE; ASTHMA; BILIRUBIN BLOOD LEVEL; BRONCHITIS; CHILL; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONSTIPATION; CREATINE KINASE BLOOD LEVEL; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; DYSGEUSIA; DYSPEPSIA; DYSPHORIA; EAR DISEASE; EOSINOPHIL COUNT; EPISTAXIS; ERYTHEMA; FEMALE; GLUCOSE BLOOD LEVEL; HAEMOPHILUS INFLUENZAE TYPE A; HEART PALPITATION; HEMATURIA; HERPES SIMPLEX; HOT FLUSH; HUMAN; HYPESTHESIA; INSOMNIA; KLEBSIELLA PNEUMONIAE; LEUKOCYTE COUNT; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL INSTABILITY; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; MUSCLE SPASM; MUSCLE WEAKNESS; NAUSEA; NEUTROPHIL COUNT; POLLAKISURIA; POSITIONAL DIZZINESS; POTASSIUM BLOOD LEVEL; PRURITUS; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; RHINOPHARYNGITIS; RHINORRHEA; SECONDARY INFECTION; SIDE EFFECT; SLEEP DISORDER; SOMNOLENCE; STAPHYLOCOCCUS AUREUS; STOMACH DISCOMFORT; STREPTOCOCCUS PNEUMONIAE; THIRST; THORAX PAIN; THROMBOCYTE COUNT; TONSILLITIS; TREATMENT DURATION; TREATMENT OUTCOME; TREMOR; UPPER ABDOMINAL PAIN; VOMITING;

EID: 69449108790     PISSN: 13407007     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Jpn J Antibiot 2006; 59: 428-451
2. Lister P D, Sanders C: Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. J Antimicrob Chemother 1999; 43: 79-86
3. Lacy M K, Lu W, Xu X, Tessier P. Nicolau D. Quintiliani R, et al: Pharmacodynamic comparisons of levofloxacin, ciprofloxacin, and ampicillin against Streptococcus pneumoniae in an in vitro model of infection. Antimicrob Agents Chemother 1999; 43: 672-677 (Pubitemid 29109538)
4. Andes D, Craig W A: Animal model pharmacokinetics and pharmacodynamics: a critical review. Int J Antimicrob Agents 2002; 19: 261-268 (Pubitemid 34308974)
5. Madaras-Kelly K J, Demasters T A: In vitro characterization of fluoroquinolone concentration/MIC antimicrobial activity and resistance while simulating clinical pharmacokinetics of levofloxacin, ofloxacin, or ciprofloxacin against Streptococcus pneumoniae. Diagn Microbiol Infect Dis 2000; 37: 253-260
6. CHEMOTHERAPY 1992; 40: 188-95
7. Okazaki O, Aoki H, Hakusui H: High-performance liquid chromatographic determination of (S)-(-)-ofloxacin and its metabolites in serum and urine using a solid-phase clean-up. J Chromatogr 1991; 563: 313-322
8. Chemotherapy 1991; 39: 687-9
9. Nightingale C H, Grant E M, Quintiliani R: Pharmacodynamics and pharmacokinetics of levofloxacia Chemotherapy 2000; 46 (S-1): 6-14